Merck Sees $24.2M in Unusual Options Activity as Traders Target Deep ITM Calls

By TrendSpider Editor

Two unusual options contracts totaling $24,228,208 in premium hit the tape for Merck & Company, Inc. on Friday, with the dominant trade being a deep in-the-money call at the $80 strike commanding $24,150,000 in premium alone. MRK shares are nearly flat on the session, down just 0.07% to $147.90,

Merck Sees $24.2M in Unusual Options Activity as Traders Target Deep ITM Calls

Two unusual options contracts totaling $24,228,208 in premium hit the tape for Merck & Company, Inc. on Friday, with the dominant trade being a deep in-the-money call at the $80 strike commanding $24,150,000 in premium alone. MRK shares are nearly flat on the session, down just 0.07% to $147.90, sitting comfortably in the upper half of its 52-week range of $77.58 to $156.92. The outsized options flow suggests sophisticated participants are making significant directional bets on Merck's trajectory heading into late 2026 and mid-2027.

Key Drivers of the MRK Stock Move

• Main Catalyst: Two unusual options contracts flagged on MRK totaling $24,228,208 in combined premium. The standout trade is a deeply in-the-money call at the $80 strike expiring June 17, 2027, with a size of 3,450 contracts and open interest utilization of just 28%. A second call at the $160 strike expiring October 23, 2026 printed 752 contracts at an OI ratio of 684%, indicating a massive surge relative to existing open interest.
• Bull Case: The $24,150,000 premium deployed in the June 2027 $80 call is a high-conviction, long-dated position with MRK trading at $147.90, meaning the contract is approximately $67.90 in the money. This type of deep ITM call structure is often used by institutions to gain leveraged equity-like exposure while defining risk, signaling strong confidence in continued upside toward and potentially beyond the 52-week high of $156.92. The October $160 call, printing at 684% of open interest, reflects aggressive near-term positioning above current prices.
• Bear Case: MRK is essentially flat today at -0.07%, failing to show any momentum despite the heavy options flow. The $160 strike call expiring October 23, 2026 is out of the money with MRK at $147.90, requiring a move of more than $12 in roughly four weeks. Open interest utilization on the larger June 2027 trade is only 28%, suggesting limited prior conviction in that contract and raising the possibility this is a hedging or synthetic equity replacement trade rather than a directional bet.

The forward setup for MRK remains defined by the tension between its deep ITM long-dated positioning and its proximity to its 52-week high of $156.92. A breakout above that ceiling would validate the bullish read on today's flow and open the door to price discovery above levels not seen in over a year. The short-term October $160 call adds urgency to the bull case, requiring meaningful upward movement before expiration on October 23, 2026. Traders will be watching closely for any fundamental catalysts, including pipeline updates or macro healthcare sector developments, that could act as the spark needed to push MRK through its current resistance ceiling.

MRK Unusual Options Activity

• Contract 1: Call | Strike: $160 | Expiry: October 23, 2026 | Volume: 752 | Open Interest Utilization: 684% | Status: OTM
• Contract 2: Call | Strike: $80 | Expiry: June 17, 2027 | Volume: 3,450 | Open Interest Utilization: 28% | Status: ITM | Premium: $24,150,000

Both contracts are calls, and with zero puts flagged in today's unusual activity scan, the directional lean of the smart money options flow is unambiguously to the upside. The total premium across both contracts reached $24,228,208, driven almost entirely by the deep ITM June 2027 position.

MRK Seasonality

Late September and early October have historically been a volatile period for large-cap pharmaceutical names as third-quarter earnings season approaches and healthcare sector rebalancing picks up. Options positioning ahead of an October expiration, as seen with the $160 call expiring October 23, 2026, often reflects traders attempting to capture any earnings-related or conference-driven price moves in the weeks ahead.

MRK Relative Performance

MRK is trading at $147.90, representing a significant recovery from its 52-week low of $77.58, with shares now sitting within roughly $9 of their 52-week high of $156.92. The near-flat session move of -0.07% suggests MRK is largely in line with broader defensive sector behavior on this Friday session, consolidating near the top of its annual range while the broader market processes end-of-week flows.